" class="no-js "lang="en-US"> Abingworth - Medtech Alert
Saturday, March 25, 2023
Abingworth | Pharmtech Focus


About Abingworth


Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs to develop their ideas into products that have a dramatic impact on health. With over $1 billion under management, Abingworth invests at all stages of development, from start-ups to publicly traded companies, and across all life sciences sectors.

Supporting its portfolio companies with a team of 25 at offices in London, Menlo Park, and Boston, Abingworth has invested in 151 life science companies, completed 65 IPOs and 42 mergers and acquisitions.

Related Story

Abingworth Raises $582 Million for New Clinical Co-development Fund – ACCD 2

May 11 2021

Abingworth, a leading international life sciences investment group, today announced the final closing of its […]